Long-term studies have found that PSA screening and early diagnosis of prostate cancer
does not save lives. Too many false positives, not enough cancer
specific and poor results.
I have seen the results of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial, in the United States, and the European Randomized Study of Screening for Prostate Cancer (ERSPC) . No difference in mortality rates with PSA and DRE screening in the PLCO trial.